Emergent BioSolutions’s Bayview facility is currently undergoing a “maintenance shutdown period” and plans to resume manufacturing services by August.
WASHINGTON — Federal and state officials now face trying to reach Americans unable or unwilling to get the COVID-19 vaccine, after meeting President Joe…
By Rachel Logan, Julia Arbutus and Pierce Panagakos When Novavax Inc. received $1.6 billion last year from the federal government to speed testing and…